HIV Control Criteria: Overview & Expert Roundtable
Although the overall number of new HIV infections has declined worldwide, it is estimated that 5000 new infections occur each day.
HIV/AIDS
HIV/AIDS
-
-
HIV & Cancer Risk: Expert Interview
Although rates of AIDS-defining malignancies have declined in recent decades, cancer remains a leading cause of mortality in people living with HIV. -
Insight Into the HIV Self-Testing Debate
Although the CDC recommends routine HIV screening for all people age 13-64 years, numerous barriers to HIV testing in healthcare settings have been identified, including lack of access and fear of stigma and discrimination. -
Telling Children Their HIV Status: Interview With Dr Elizabeth Lowenthal
Infectious Disease Advisor speaks with Elizabeth D. Lowenthal, MD, about the challenges associated with revealing HIV seropositive status to children. -
Psychosocial Interventions in HIV: How Best to Support HIV-Positive Patients
Mental health professionals supporting patients living with HIV need to make space for their patients to process the emotional effect of their diagnosis, but not to make assumptions about what it means to them.
Latest News
STI Incidence Increased After Receipt of HIV Preexposure Prophylaxis
Younger age, greater partner number, group sex, but not condom use, linked to increased risk of STI
Rifapentine Plus Isoniazid Noninferior to Isoniazid in HIV-Related TB
For prevention of TB in people with HIV, a single month regimen of rifapentine plus isoniazid was noninferior to 9 months of isoniazid alone.
HIV Transmission Rates Decreased With Prompt Diagnosis and Treatment
Viral suppression has become increasingly prevalent in people with HIV infection in recent years, and the rates of new infections and transmissions have been decreasing.
Hepatic Steatosis Highly Prevalent in Young Adults With Lifelong HIV
One-third of young adults living with HIV since birth or early childhood have hepatic steatosis.
Dual Therapy With Rilpivirine and Boosted Darunavir Is Effective in PLWHIV
Rilpivirine plus boosted-darunavir dual therapy may be effective and safe in patients with advanced HIV.
A Global Meta-Analysis on HIV, HCV, and HBV in People Who Inject Drugs
Investigators assessed country, regional, and global incidence of serologically confirmed HIV, anti-hepatitis C virus, and hepatitis B virus prevalence according to gender in people who inject drugs.
Noninvasive Fibrosis Assessments Recommended in Patients With HIV
Noninvasive tools with a high negative predictive value for significant liver fibrosis may reduce the number of liver biopsies in HIV mono-infection.
Increased Levels of CMV DNA Found in African Children With Perinatally Acquired HIV
Significant levels of cytomegalovirus DNA are common in older African children with perinatally acquired HIV infection.
Predictors of Doravirine Resistance After Exposure to NNRTIs
Doravirine resistance is uncommon in people with HIV who have been treated with non-nucleoside reverse transcriptase inhibitors.
First Two-Drug Regimen Approved for HIV-1 Treatment
The FDA has announced the approval of Dovato for adults with HIV-1 who have not been previously treated with antiretroviral medication.
Dolutegravir Feasible for HIV Treatment in Women of Childbearing Age
Dolutegravir should be considered for ART in treating HIV in women of childbearing potential.
AACR: HPV Vaccine Rate Low for Adults at High Risk for HIV
Age, sex, sexual orientation differences in HPV vaccination rates were statistically significant.
Depressive Symptoms May Increase Risk for Death in Veterans With HIV
However, depression linked to higher risk for death in HIV-uninfected, but not HIV-infected, U.S. veterans
Early Onset Overweight, Stunting Seen in Children Exposed to HIV and ART
A study shows that there are small but consistent deficits in the early growth trajectories of young children who were breastfed and exposed to HIV.
Marijuana Use and CD4 Values Associated With Increased PCSK9 Levels in PLWHIV
Higher proprotein convertase subtilisin/kexin 9 levels are associated with marijuana consumption and low CD4 values in people living with HIV.
Non-HIV Pneumocystis Jirovecii Pneumonia Survival Predicted by CT Patterns
The presence of low serum albumin and crazy paving ground glass opacities on high-resolution computed tomography at the time of non-HIV Pneumocystis jirovecii pneumonia diagnosis were predictive of poor prognosis.
National Sample Shows 40% of Patients Adhere to Full PrEP Schedule
Results showed substantial nonpersistence of PrEP for HIV prevention in both year 1 and 2, with only 40% of users adhering for the entire 2-year period.
Persistent Low-Level Viremia May Increase Virologic Failure Risk in PLWHIV
In people with HIV, persistent low-level viremia may be an independent predictor of virologic failure and needs further investigation.
Increased Transmitted Drug-Resistance Mutations of Non-B HIV Subtypes
Prevalence of transmitted-drug-resistance-associated mutations were stable from 2010-2011 to 2015-2016, but there was an increase in HIV non-B subtypes.
Impaired Insulin Sensitivity in PLWHIV Associated With Cognitive Decline
People living with HIV and declining cognition exhibit hyperinsulinemia, as well as abnormal cholesterol and lipid metabolism.
Want to read more?
Please login or register first to view this content.
Next post in News
